Biology subjects

Waman, V. P.

Publications and source records attributed to Waman, V. P..

7 recordsLinked to original sources

bioRxiv2026

TEDLH: Domain HMMs for sensitive detection of remote homologues

MotivationThe Encyclopedia of Domains (TED) provides domain annotations for proteins in the AlphaFold Protein Structure Database (AFDB) using a consensus of three state-of-the-art structure-based methods. We used these TED domain annotations to construct profile Hidden Markov models (HMMs), collectively forming the TED Library of HMMs (TEDLH). TEDLH enables sensitive sequence and profile searches, supporting systematic exploration of protein domain families and their evolutionary relationships. ResultsTEDLH links domain HMMs to experimentally determined CATH-PDB structures through direct (primary) and transitive (secondary and tertiary) relationships. Fewer than half of TEDLH HMMs are directly linked to a CATH-PDB domain; the remaining models are connected through transitive relationships. These transitive links extend coverage into more divergent regions of sequence space and better represent CATH superfamily diversity. HMM-HMM comparisons within CATH superfamily 3.30.70.100 illustrate how transitive relationships expand sequence coverage in TEDLH. In this superfamily, 4,813 TEDLH HMMs are connected to 212 CATH-PDB representatives. Primary, secondary, and tertiary relationships progressively capture more divergent sequences (pairwise sequence identity <20%) that retain structural similarity (TM-score >0.6) and a conserved two-layer /{beta} sandwich core fold. All-against-all HMM-HMM comparisons across TEDLH also reveal sequence similarities across the CATH hierarchy (cross-hits). At low query coverage (<50%), cross-hits are more frequent between CATH classes, whereas at higher coverage thresholds (>70%) they predominantly occur between superfamilies. These cross-hits are not driven by superfamily size or sequence diversity and can provide guidance for CATH curation. As an example, analysis of cross-hits between superfamilies 2.170.130.30 and 3.10.20.30 reveals evolutionary relationships between these groups. Availability and ImplementationTEDLH is compatible with HH-suite3 and is available from FigShare https://doi.org/10.6084/m9.figshare.28531754 for local use. Contactc.carreno@ucl.ac.uk

bioinformatics↗

bioRxiv2024

Exploring structural diversity across the protein universe with The Encyclopedia of Domains

The AlphaFold Protein Structure Database (AFDB) contains full-length predictions of the three-dimensional structures of almost every protein in UniProt. Because protein function is closely linked to structure, the AFDB is poised to revolutionise our understanding of biology, evolution and more. Protein structures are composed of domains, independently folding units that can be found in multiple structural contexts and functional roles. The AFDBs potential remains untapped due to the difficulty of characterising 200 million structures. Here we present The Encyclopedia of Domains or TED, which combines state-of-the-art deep learning-based domain parsing and structure comparison algorithms to segment and classify domains across the whole AFDB. TED describes over 370 million domains, over 100 million more than detectable by sequence-based methods. Nearly 80% of TED domains share similarities to known superfamilies in CATH, greatly expanding the set of known protein structural domains. We uncover over 10,000 previously unseen structural interactions between superfamilies, expand domain coverage to over 1 million taxa, and unveil thousands of architectures and folds across the unexplored continuum of protein fold space. We expect TED to be a valuable resource that provides a functional interface to the AFDB, empowering it to be useful for a multitude of downstream analyses.

bioinformatics↗

bioRxiv2023

Predicting human and viral protein variants affecting COVID-19 susceptibility and repurposing therapeutics

The COVID-19 disease is an ongoing global health concern. Although vaccination provides some protection, people are still susceptible to re-infection. Ostensibly, certain populations or clinical groups may be more vulnerable. Factors causing these differences are unclear and whilst socioeconomic and cultural differences are likely to be important, human genetic factors could influence susceptibility. Experimental studies indicate SARS-CoV-2 uses innate immune suppression as a strategy to speed-up entry and replication into the host cell. Therefore, it is necessary to understand the impact of variants in immunity-associated human proteins on susceptibility to COVID-19. In this work, we analysed missense coding variants in several SARS-CoV-2 proteins and its human protein interactors that could enhance binding affinity to SARS-CoV-2. We curated a dataset of 19 SARS-CoV-2: human protein 3D-complexes, from the experimentally determined structures in the Protein Data Bank and models built using AlphaFold2-multimer, and analysed impact of missense variants occurring in the protein-protein interface region. We analysed 468 missense variants from human proteins and 212 variants from SARS-CoV-2 proteins and computationally predicted their impacts on binding affinities to SARS-CoV-2 proteins, using 3D-complexes. We predicted a total of 26 affinity-enhancing variants from 14 human proteins implicated in increased binding affinity to SARS-CoV-2. These include key-immunity associated genes (TOMM70, ISG15, IFIH1, IFIT2, RPS3, PALS1, NUP98, RAE1, AXL, ARF6, TRIMM, TRIM25) as well as important spike receptors (KREMEN1, AXL and ACE2). We report both common (e.g., Y13N in IFIH1) and rare variants in these proteins and discuss their likely structural and functional impact, using information on known and predicted functional sites. Potential mechanisms associated with immune suppression implicated by these variants are discussed. Occurrence of certain predicted affinity-enhancing variants should be monitored as they could lead to increased susceptibility and reduced immune response to SARS-CoV-2 infection in individuals/populations carrying them. Our analyses aid in understanding the potential impact of genetic variation in immunity-associated proteins on COVID-19 susceptibility and help guide drug-repurposing strategies.

bioinformatics↗

bioRxiv2022

AlphaFold2 reveals commonalities and novelties in protein structure space for 21 model organisms

Over the last year, there have been substantial improvements in protein structure prediction, particularly in methods like DeepMinds AlphaFold2 (AF2) that exploit deep learning strategies. Here we report a new CATH-Assign protocol which is used to analyse the first tranche of AF2 models predicted for 21 model organisms and discuss insights these models bring on the nature of protein structure space. We analyse good quality models and those with no unusual structural characteristics, i.e., features rarely seen in experimental structures. For the [~]370,000 models that meet these criteria, we observe that 92% can be assigned to evolutionary superfamilies in CATH. The remaining domains cluster into 2,367 putative novel superfamilies. Detailed manual analysis on a subset of 618 of those which had at least one human relative revealed some extremely remote homologies and some further unusual features, but 26 could be confirmed as novel superfamilies and one of these has an alpha-beta propeller architectural arrangement never seen before. By clustering both experimental and predicted AF2 domain structures into distinct global fold groups, we observe that the new AF2 models in CATH increase information on structural diversity by 36%. This expansion in structural diversity will help to reveal associated functional diversity not previously detected. Our novel CATH-Assign protocol scales well and will be able to harness the huge expansion (at least 100 million models) in structural data promised by DeepMind to provide more comprehensive coverage of even the most diverse superfamilies to help rationalise evolutionary changes in their functions.

bioinformatics↗

bioRxiv2021

Insertions in the SARS-CoV-2 Spike N-Terminal Domain May Aid COVID-19 Transmission

Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 is an ongoing pandemic that causes significant health/socioeconomic burden. Variants of concern (VOCs) have emerged which may affect transmissibility, disease severity and re-infection risk. Most studies focus on the receptor-binding domain (RBD) of the Spike protein. However, some studies suggest that the Spike N-terminal domain (NTD) may have a role in facilitating virus entry via sialic-acid receptor binding. Furthermore, most VOCs include novel NTD variants. Recent analyses demonstrated that NTD insertions in VOCs tend to lie close to loop regions likely to be involved in binding sialic acids. We extended the structural characterisation of these putative sugar binding pockets and explored whether variants could enhance the binding to sialic acids and therefore to the host membrane, thereby contributing to increased transmissibility. We found that recent NTD insertions in VOCs (i.e., Gamma, Delta and Omicron variants) and emerging variants of interest (VOIs) (i.e., Iota, Lambda, Theta variants) frequently lie close to known and putative sugar-binding pockets. For some variants, including the recent Omicron VOC, we find increases in predicted sialic acid binding energy, compared to the original SARS-CoV-2, which may contribute to increased transmission. We examined the similarity of NTD across a range of related Betacoronaviruses to determine whether the putative sugar-binding pockets are sufficiently similar to be exploited in drug design. Despite global sequence and structure similarity, most sialic-acid binding pockets of NTD vary across related coronaviruses. Typically, SARS-CoV-2 possesses additional loops in these pockets that increase contact with polysaccharides. Our work suggests ongoing evolutionary tuning of the sugar-binding pockets in the virus. Whilst three of the pockets are too structurally variable to be amenable to pan Betacoronavirus drug design, we detected a fourth pocket that is highly structurally conserved and could therefore be investigated in pursuit of a generic drug. Our structure-based analyses help rationalise the effects of VOCs and provide hypotheses for experiments. For example, the Omicron variant, which has increased binding to sialic acids in pocket 3, has a rather unique insertion near pocket 3. Our work suggests a strong need for experimental monitoring of VOC changes in NTD.

bioinformatics↗

bioRxiv2020

SARS-CoV-2 spike protein predicted to form stable complexes with host receptor protein orthologues from mammals, but not fish, birds or reptiles

SARS-CoV-2 has a zoonotic origin and was transmitted to humans via an undetermined intermediate host, leading to infections in humans and other mammals. To enter host cells, the viral spike protein (S-protein) binds to its receptor, ACE2, and is then processed by TMPRSS2. Whilst receptor binding contributes to the viral host range, S-protein:ACE2 complexes from other animals have not been investigated widely. To predict infection risks, we modelled S-protein:ACE2 complexes from 215 vertebrate species, calculated changes in the energy of the complex caused by mutations in each species, relative to human ACE2, and correlated these changes with COVID-19 infection data. We also analysed structural interactions to better understand the key residues contributing to affinity. We predict that mutations are more detrimental in ACE2 than TMPRSS2. Finally, we demonstrate phylogenetically that human SARS-CoV-2 strains have been isolated in animals. Our results suggest that SARS-CoV-2 can infect a broad range of mammals, but few fish, birds or reptiles. Susceptible animals could serve as reservoirs of the virus, necessitating careful ongoing animal management and surveillance.

bioinformatics↗

bioRxiv2019

Comparative analyses of metabolic pathways in mycobacteria: Insights into the identification and characterisation of new drug targets in M. tuberculosis, M. leprae and M. abscessus

Three related mycobacteria are the cause of widespread infections in man and are the focus of intense research and drug-discovery efforts in the face of growing antimicrobial resistance. Mycobacterium tuberculosis, the causative agent of tuberculosis, is currently one of the top ten causes of death in the world according to WHO; M. abscessus, a group of non-tuberculous mycobacteria causes lung infections and other opportunistic infections in humans; and M. leprae, the causative agent of leprosy, remains endemic in tropical countries. There is an urgent need to design alternatives to conventional treatment strategies, due to the increase in resistance to standard antibacterials. In this study, we present a comparative analysis of chokepoint and essentiality datasets that will provide insight into the development of new treatment regimes. We illustrate the key metabolic pathways shared between these three organisms and identify drug targets with a wide metabolic impact that are common to the three species. We demonstrate that 72% of the chokepoint enzymes are proteins essential to Mycobacterium tuberculosis. We show also that 78% of the drug targets, prioritized based on their presence in multiple paths on the metabolic network, are present in pathways shared by M. tuberculosis, M. leprae and M. abscessus, including biosynthesis of amino acids, carbohydrates, cell structures, fatty acid and lipid biosynthesis. A further 17% is found in the prioritised pathways shared between M. tuberculosis and M. abscessus. We have performed comparative structure modelling of potential drug targets identified using our analysis in order to assess druggability and demonstrate the importance of chokepoint analysis in terms of drug target identification. AUTHOR SUMMARYComputer simulation studies to design new drugs against mycobacteria

bioinformatics↗